Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomerizotide Injection in Postoperative Hepatocellular Carcinoma
CTR20131695Phase 3Active
- Sponsor
- Sino Biological
- Start
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lomerizotide in hepatocellular carcinoma (HCC), sponsored by Sino Biological. Started Mar 2014; status: active.
02
Drugs
lomerizotide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20131695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131695.